OTHER NEWS - July 3, 1996
Times Staff and Wire Reports
Gene Research Firms Add Partners: Two companies researching human genes to treat cancer, prevent heart attacks and cure other diseases said they have so many new drug possibilities that they have enlisted two more partners to share the work. Human Genome Sciences Inc. and SmithKline Beecham--partners in the gene project since 1993--announced research collaborations with U.S. drug maker Schering Plough Corp. and Synthelabo, a big French drug company. Schering and Synthelabo will pay Human Genome and SmithKline a total of $90 million over five years in exchange for access to Human Genome’s massive computer database of nearly all of the roughly 100,000 human genes. The four new partners will conduct separate research projects.
